Adequacy of access to investigative drugs for seriously ill patients : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, first session, September 23, 1997

LDR 03279cam a2200577 a 4500
001 007604372
003 MiAaHDL
005 20250106000000.0
006 m d
007 cr bn ---auaua
008 980331s1997 dcu f000 0 eng c
010 ⊔ ⊔ ‡a 98133492
020 ⊔ ⊔ ‡a9780160557590
020 ⊔ ⊔ ‡a0160557593
035 ⊔ ⊔ ‡a(MiU)990047028190106381
035 ⊔ ⊔ ‡asdr-miu.990047028190106381
035 ⊔ ⊔ ‡asdr-pst.a1470311
035 ⊔ ⊔ ‡z(MiU)MIU01000000000000004702819-goog
035 ⊔ ⊔ ‡a(OCoLC)38166389
035 ⊔ ⊔ ‡z(MiU)Aleph004702819
040 ⊔ ⊔ ‡aDGPO/DLC ‡beng ‡cGPO ‡dDLC ‡dBTCTA ‡dYDXCP ‡dCZL ‡dOCLCF ‡dCOF ‡dOCL ‡dOCLCO ‡dOCLCQ ‡dUOK ‡dOCLCQ
043 ⊔ ⊔ ‡an-us---
050 0 0 ‡aKF27 ‡b.E5546 1997d
074 ⊔ ⊔ ‡a1019-B-01 (MF)
074 ⊔ ⊔ ‡a1019-A-01
082 1 4 ‡a4.C 73/8:105-44
086 0 ⊔ ‡aY 4.C 73/8:105-44
088 ⊔ ⊔ ‡aSerial no. 105-44 (United States. Congress. House. Committee on Commerce)
110 1 ⊔ ‡aUnited States. ‡bCongress. ‡bHouse. ‡bCommittee on Commerce. ‡bSubcommittee on Oversight and Investigations. ‡0http://id.loc.gov/authorities/names/no95033770 ‡1http://id.loc.gov/rwo/agents/no95033770
245 1 0 ‡aAdequacy of access to investigative drugs for seriously ill patients : ‡bhearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, first session, September 23, 1997.
260 ⊔ ⊔ ‡aWashington : ‡bU.S. G.P.O. : ‡bFor sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, ‡c1997.
300 ⊔ ⊔ ‡aiii, 78 pages ; ‡c24 cm
336 ⊔ ⊔ ‡atext ‡btxt ‡2rdacontent
337 ⊔ ⊔ ‡aunmediated ‡bn ‡2rdamedia
338 ⊔ ⊔ ‡avolume ‡bnc ‡2rdacarrier
500 ⊔ ⊔ ‡a"Serial no. 105-44."
500 ⊔ ⊔ ‡aShipping list no.: 98-0082-P.
500 ⊔ ⊔ ‡aDistributed to some depository libraries in microfiche.
530 ⊔ ⊔ ‡aAlso available in digital form on the Library of Congress Web site.
538 ⊔ ⊔ ‡aMode of access: Internet.
650 ⊔ 7 ‡aPharmacology, Experimental. ‡2fast ‡0http://id.worldcat.org/fast/1060280
650 ⊔ 7 ‡aMedical ethics. ‡2fast ‡0http://id.worldcat.org/fast/1014081
650 ⊔ 7 ‡aHuman experimentation in medicine. ‡2fast ‡0http://id.worldcat.org/fast/963042
650 ⊔ 7 ‡aDrugs ‡xTesting. ‡2fast ‡0http://id.worldcat.org/fast/898940
650 ⊔ 7 ‡aDrug accessibility ‡xLaw and legislation. ‡2fast ‡0http://id.worldcat.org/fast/1941193
650 ⊔ 7 ‡aClinical trials. ‡2fast ‡0http://id.worldcat.org/fast/864429
650 ⊔ 0 ‡aDrug accessibility ‡xLaw and legislation ‡zUnited States.
650 ⊔ 0 ‡aMedical ethics ‡zUnited States. ‡0http://id.loc.gov/authorities/subjects/sh2008107620
650 ⊔ 0 ‡aHuman experimentation in medicine ‡zUnited States. ‡0http://id.loc.gov/authorities/subjects/sh2008122022
650 ⊔ 0 ‡aClinical trials ‡zUnited States. ‡0http://id.loc.gov/authorities/subjects/sh2009120434
650 ⊔ 0 ‡aDrugs ‡zUnited States ‡xTesting. ‡0http://id.loc.gov/authorities/subjects/sh2009123883
650 ⊔ 0 ‡aPharmacology, Experimental ‡zUnited States.
651 ⊔ 7 ‡aUnited States. ‡2fast ‡0http://id.worldcat.org/fast/1204155
776 0 8 ‡iOnline version: ‡aUnited States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations. ‡dWashington : U.S.G.P.O. : For sale by the U.S.G.P.O., Supt. of Docs., Congressional Sales Office, 1997 ‡w(OCoLC)647306362
899 ⊔ ⊔ ‡a39015051641762
CID ⊔ ⊔ ‡a007604372
DAT 0 ⊔ ‡a20241218071206.0 ‡b20250106000000.0
DAT 1 ⊔ ‡a20250107192053.0 ‡b2025-01-08T14:44:49Z
DAT 2 ⊔ ‡a2024-07-15T17:30:02Z ‡b2020-08-29T20:00:02Z
CAT ⊔ ⊔ ‡aSDR-MIU ‡cmiu ‡dALMA ‡lprepare.pl-004-009
FMT ⊔ ⊔ ‡aBK
HOL ⊔ ⊔ ‡0sdr-miu.990047028190106381 ‡aMiU ‡bSDR ‡cMIU ‡f004702819 ‡pmdp.39015051641762 ‡sMIU ‡1990047028190106381
974 ⊔ ⊔ ‡bMIU ‡cMIU ‡d20250108 ‡sgoogle ‡umdp.39015051641762 ‡y1997 ‡rpd ‡qbib ‡tUS fed doc
974 ⊔ ⊔ ‡bPST ‡cPST ‡d20231120 ‡sgoogle ‡upst.000032202519 ‡z4.C 73/8:105-44 ‡y1997 ‡rpd ‡qbib ‡tUS fed doc